Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-14 4:25 pm Sale | 13G | Nightstar Therapeutics plc NITE | Redmile Group LLC | 0 0% | -1,795,846 (Position Closed) | View |
| 2020-02-04 1:01 pm Sale | 13G | Nightstar Therapeutics plc NITE | Woodford Investment Management Ltd | 0 0% | -1,921,315 (Position Closed) | View |
| 2019-06-12 3:52 pm Sale | 13D | Nightstar Therapeutics plc NITE | New Enterprise Associates 15 L.P. | 0 0% | -6,662,532 (Position Closed) | View |
| 2019-04-25 11:50 am Purchase | 13D | Nightstar Therapeutics plc NITE | Polygon Global Partners LLP | 2,672,779 7.97% | 2,672,779 (New Position) | View |
| 2019-04-10 10:19 am Sale | 13G | Nightstar Therapeutics plc NITE | WELLINGTON MANAGEMENT GROUP LLP | 0 0% | -3,071,865 (Position Closed) | View |
| 2019-03-14 5:00 pm Purchase | 13D | Nightstar Therapeutics plc NITE | BIOGEN INC. BIIB | 20,638,209 61.6% | 20,638,209 (New Position) | View |
| 2019-03-14 4:25 pm Unchanged | 13G | Nightstar Therapeutics plc NITE | Syncona Portfolio Ltd | 13,203,922 39% | 0 (Unchanged) | View |
| 2019-03-13 07:22 am Unchanged | 13D | Nightstar Therapeutics plc NITE | New Enterprise Associates 15 L.P. | 6,662,532 19.9% | 0 (Unchanged) | View |
| 2019-02-14 4:01 pm Purchase | 13G | Nightstar Therapeutics plc NITE | Redmile Group LLC | 1,795,846 5.4% | 23,003 (+1.30%) | View |
| 2019-02-14 3:45 pm Purchase | 13G | Nightstar Therapeutics plc NITE | Woodford Investment Management Ltd | 1,921,315 5.8% | 1,921,315 (New Position) | View |
| 2019-02-14 3:04 pm Sale | 13G | Nightstar Therapeutics plc NITE | Point72 Asset Management L.P. | 1,339,355 4% | -162,838 (-10.84%) | View |
| 2019-02-13 5:06 pm Purchase | 13G | Nightstar Therapeutics plc NITE | Syncona Portfolio Ltd | 13,203,922 39% | 1,000,000 (+8.19%) | View |
| 2019-02-12 09:31 am Purchase | 13G | Nightstar Therapeutics plc NITE | WELLINGTON MANAGEMENT GROUP LLP | 3,071,865 10.63% | 65,408 (+2.18%) | View |
| 2018-11-13 08:07 am Purchase | 13G | Nightstar Therapeutics plc NITE | WELLINGTON MANAGEMENT GROUP LLP | 3,006,457 10.41% | 1,191,720 (+65.67%) | View |
| 2018-10-09 09:39 am Purchase | 13D | Nightstar Therapeutics plc NITE | New Enterprise Associates 15 L.P. | 6,662,532 20.3% | 500,000 (+8.11%) | View |
| 2018-08-10 09:41 am Sale | 13G | Nightstar Therapeutics plc NITE | WELLINGTON MANAGEMENT GROUP LLP | 1,814,737 6.28% | -1,605,063 (-46.93%) | View |
| 2018-08-07 5:26 pm Purchase | 13G | Nightstar Therapeutics plc NITE | Point72 Asset Management L.P. | 1,502,193 5.2% | 1,502,193 (New Position) | View |
| 2018-07-27 4:11 pm Purchase | 13G | Nightstar Therapeutics plc NITE | Redmile Group LLC | 1,772,843 6.1% | 1,772,843 (New Position) | View |